Abstract 030 | Expression of the ERG1A potassium channel affects nanoscale membrane characteristics of cultured skeletal muscle cells

Rhabdomyosarcoma (RMS) is a rare skeletal muscle (SKM) cancer with an overall incidence rate of approximately 4.5 cases per million in the U.S, this being similar among countries around the world with the exception of East Asia where it is about 2 cases per million [1]. It is generally diagnosed in children and teens and has a five-year survival rate ranging from 30-90%, dependent upon whether it is diagnosed as low, intermediate, or high risk [2,3,4]. There are two key types: 1) embryonic (ERMS) and 2) alveolar (ARMS); the ARMS form is the more aggressive and is less easily treated [2,3,4]. We have reported that the ERG1 voltage-gated K+ channel is detected in RMS cells by immunohistochemistry [5] and our preliminary immunoblots show that the mature glycosylated isoforms are more abundant in the RMS cells than in the control C2C12 cells. Indeed, the ERG1A channel is associated with numerous cancer cell types and, although it is associated with poor prognoses, what role it plays in malignancy is not known [6]. Certain membrane mechanical properties differ in malignant versus normal cells. For example, cancer cell membranes have been reported to exhibit decreased “stiffness” [7,8] as well as altered adhesion [7,8] and deformation [9]. We have preliminary atomic force microscopy (AFM) data which show that ERG1A over-expression in C2C12 myoblasts significantly increased membrane adhesion by 6.6 fold (p